L-arginine catabolism is driven mainly towards nitric oxide synthesis in the erythrocytes of patients with type 2 diabetes at first clinical onset

Annals of Clinical Biochemistry

Volumn 52, Issue 1, 2015, Pages 135-143

  Savu, Octavian ^a   Iosif, Liviu ^b   Bradescu, Ovidiu Marius ^a   Serafinceanu, Cristian ^a   Papacocea, Raluca ^c   Stoian, Irina ^b,c  

^a National Institute of Diabetes   (Romania)

^b R D Irist Labmed SRL   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

l arginine; nitric oxide; type 2 diabetes

Indexed keywords

ARGINASE; ARGININE; HEMOGLOBIN A1C; NITRATE; NITRIC OXIDE; NITRITE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; NITRIC ACID DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SPECTROPHOTOMETRY; SYNTHESIS; TURBIDIMETRY; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, TYPE 2; HYPERTENSION; METABOLISM; MIDDLE AGED;

ARGINASE; ARGININE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROPHORESIS, CAPILLARY; ERYTHROCYTES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES;

EID: 84918812671     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214531739     Document Type: Article

References (46)

1. Wu G,Morris SM.Arginine metabolism: nitric oxide and beyond.Biochem J. 1998;336 (Pt 1): 1-17
2. Li H,Meininger CJ,Hawker JR, et al.Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.Am J Physiol Endocrinol Metab. 2001;280:E75-E82
3. Morris SM.Arginine metabolism: boundaries of our knowledge.J Nutr. 2007;137:1602S-1609S
4. Li H,Meininger CJ,Kelly KA, et al.Activities of arginase I and II are limiting for endothelial cell proliferation.Am J Physiol Regul Integr Comp Physiol. 2002;282:R64-R69
5. Kim PS,Iyer RK,Lu KV, et al.Expression of the liver form of arginase in erythrocytes.Mol Genet Metab. 2002;76:100-110
6. Ignarro LJ.Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.Pharm Res. 1989;6:651-659
7. Alderton WK,Cooper CE,Knowles RG.Nitric oxide synthases: structure, function and inhibition.Biochem J. 2001;357 (Pt 3): 593-615
8. Chen K,Popel AS.Nitric oxide production pathways in erythrocytes and plasma.Biorheology. 2009;46:107-119
9. Kleinbongard P,Schulz R,Rassaf T, et al.Red blood cells express a functional endothelial nitric oxide synthase.Blood. 2006;107:2943-2951
10. Li H,Cui H,Kundu TK, et al.Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase.J Biol Chem. 2008;283:17855-17863
11. Zweier JL,Wang P,Samouilov A, et al.Enzyme-independent formation of nitric oxide in biological tissues.Nat Med. 1995;1:804-809
12. Huang Z,Shiva S,Kim-Shapiro DB, et al.Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control.J Clin Invest. 2005;115:2099-2107
13. Wu G,Meininger CJ.Arginine nutrition and cardiovascular function.J Nutr. 2000;130:2626-2629
14. Kashyap SR,Lara A,Zhang R, et al.Insulin reduces plasma arginase activity in type 2 diabetic patients.Diabetes Care. 2008;31:134-139
15. Chen LY,Mehta JL.Evidence for the presence of L-arginine-nitric oxide pathway in human red blood cells: relevance in the effects of red blood cells on platelet function.J Cardiovasc Pharmacol. 1998;32:57-61
16. Marklund S,Marklund G.Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase.Eur J Biochem. 1974;47:469-474
17. Zinellu A,Sotgia S,Usai MF, et al.Improved method for plasma ADMA, SDMA, and arginine quantification by field-amplified sample injection capillary electrophoresis UV detection.Anal Bioanal Chem. 2011;399:1815-1821
18. Green JS,Jorgenson JW.Minimizing adsorption of proteins on fused silica in capillary zone electrophoresis by the addition of alkali metal salts to the buffers.J Chromatogr A. 1989;478:63-70
19. Fukumoto K,Karai I,Nishikawa Y, et al.Erythrocyte arginase activity as an indicator of lead exposure.Br J Ind Med. 1983;40:106-110
20. Miranda KM,Espey MG,Wink DA.A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite.Nitric Oxide. 2001;5:62-71
21. Groche D,Hoeno W,Hoss G, et al.Standardization of two immunological HbA1c routine assays according to the new IFCC reference method.Clin Lab. 2003;49:657-661
22. Chien R-L,Burgi DS.Field amplified sample injection in high-performance capillary electrophoresis.J Chromatogr A. 1991;559:141-152
23. Viinikka L.Nitric oxide as a challenge for the clinical chemistry laboratory.Scand J Clin Lab Invest. 1996;56:577-581
24. Kim-Shapiro DB,Schechter AN,Gladwin MT.Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics.Arterioscler Thromb Vasc Biol. 2006;26:697-705
25. Ramirez-Zamora S,Mendez-Rodriguez ML,Olguin-Martinez M, et al.Increased erythrocytes by-products of arginine catabolism are associated with hyperglycemia and could be involved in the pathogenesis of type 2 diabetes mellitus.PLoS One. 2013;8:e66823-e66823
26. Moss MB,Brunini TM,Soares De Moura R, et al.Diminished L-arginine bioavailability in hypertension.Clin Sci (Lond). 2004;107:391-397
27. Deves R,Chavez P,Boyd CA.Identification of a new transport system (y+L) in human erythrocytes that recognizes lysine and leucine with high affinity.J Physiol. 1992;454:491-501
28. Hanssen H,Brunini TM,Conway M, et al.Increased L-arginine transport in human erythrocytes in chronic heart failure.Clin Sci (Lond). 1998;94:43-48
29. Mendes Ribeiro AC,Brunini TM,Yaqoob M, et al.Identification of system y+L as the high-affinity transporter for L-arginine in human platelets: up-regulation of L-arginine influx in uraemia.Pflugers Arch. 1999;438:573-575
30. Jiang M,Jia L,Jiang W, et al.Protein disregulation in red blood cell membranes of type 2 diabetic patients.Biochem Biophys Res Commun. 2003;309:196-200
31. Jiang M,Ding Y,Su Y, et al.Arginase-flotillin interaction brings arginase to red blood cell membrane.FEBS Lett. 2006;580:6561-6564
32. Durante W,Johnson FK,Johnson RA.Arginase: a critical regulator of nitric oxide synthesis and vascular function.Clin Exp Pharmacol Physiol. 2007;34:906-911
33. Moss MB,Siqueira MA,Mann GE, et al.Platelet aggregation in arterial hypertension: is there a nitric oxide-urea connection?.Clin Exp Pharmacol Physiol. 2010;37:167-172
34. Mendes Ribeiro AC,Brunini TM,Ellory JC, et al.Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure.Cardiovasc Res. 2001;49:697-712
35. Bogle RG,Baydoun AR,Pearson JD, et al.L-arginine transport is increased in macrophages generating nitric oxide.Biochem J. 1992;284 (Pt 1): 15-18
36. Boger RH.Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “L-arginine paradox” and acts as a novel cardiovascular risk factor.J Nutr. 2004;134:2842S-2847S
37. Palmerini CA,Zucchi A,Fioretti F, et al.Erectile dysfunction and NO: variations of NO penile blood levels before and after sildenafil treatment.Int J Impot Res. 2009;21:321-325
38. Brunini T,Roberts N,Yaqoob M, et al.Activation of L-arginine transport in peripheral blood mononuclear cells in chronic renal failure.Pflugers Arch. 2002;445:147-151
39. Zahedi Asl S,Ghasemi A,Azizi F.Serum nitric oxide metabolites in subjects with metabolic syndrome.Clin Biochem. 2008;41:1342-1347
40. Huszka M,Kaplar M,Rejto L, et al.The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus.Thromb Res. 1997;86:173-180
41. Vanizor B,Orem A,Karahan SC, et al.Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications.Diabetes Res Clin Pract. 2001;54:33-39
42. Ferlito S,Gallina M.Nitrite plasma levels in type 1 and 2 diabetics with and without complications.Minerva Endocrinol. 1999;24:117-121
43. Maejima K,Nakano S,Himeno M, et al.Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications.J Diabetes Complications. 2001;15:135-143
44. Dejam A,Hunter CJ,Pelletier MM, et al.Erythrocytes are the major intravascular storage sites of nitrite in human blood.Blood. 2005;106:734-739
45. Sibmooh N,Piknova B,Rizzatti F, et al.Oxidation of iron-nitrosyl-hemoglobin by dehydroascorbic acid releases nitric oxide to form nitrite in human erythrocytes.Biochemistry. 2008;47:2989-2996
46. Cosby K,Partovi KS,Crawford JH, et al.Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.Nat Med. 2003;9:1498-1505